Advances in Graft vs. Host Disease Treatment Webinar

Make the Most Out of Life with Graft Versus Host Disease 

Graft versus Host Disease (GVHD) is a potentially life-threatening condition, affecting 40-50% of blood cancer patients who receive an allogeneic stem cell transplant. 

Join transplant experts, including Roswell Park's Dr. Shernan Holtan, Chief of Blood and Marrow Transplantation, for an informative online discussion, explaining topics on:

• What GVHD is and the differences between acute and chronic forms
• Preparing for a stem cell transplant
• Risks of GVHD 
• How to watch for symptoms
• Current treatments available and new clinical trials aimed at prevention and treatment

Learn more and register here

This program is hosted by the Leukemia and Lymphoma Society and The Patient Story.